The largest database of trusted experimental protocols

10 protocols using rl95 2

1

Characterizing Effects of Antibiotics on HESC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Detailed methodology on isolation of HESCs can be found in supplemental Methods. HESCs were seeded in 96-well plates (2 × 103 cells per well) and incubated in DMEM/F-12 containing 10% FBS and 24 μg/ml ABs. Ishikawa cells were purchased from Procell Ltd. (RL95-2, Wuhan, China) and cultured in DMEM/F12 plus 10% FBS in 96-well plates (1 × 103 cells per well). The proliferative behaviors of HESCs and Ishikawa cells were evaluated using a cell counting kit-8 (CCK-8) assay (Dojindo, Shanghai, China) according to the manufacturer's protocol. Cells cultured by DMEM/F-12 with 10% FBS served as controls.
To evaluate the effect of ABs on migration of HESCs, cells were seeded into 6-well plates (3 × 105 cells per well) and cultured in DMEM/F-12 containing 10% FBS until confluent monolayers. A linear wound was made using a 200 μL pipette tip. After washed with PBS, cells were incubated in DMEM/F-12 containing 10% FBS and 24 μg/ml ABs. The area of the scratch was measured at 0 h, 6 h and 24 h through taking six representative images. The closure rate was calculated as follows:
To evaluate the effect of ABs on fibrotic gene expression of HESCs, qRT-PCR on fibrotic genes (Col IA2, Fibronectin [FN], connective tissue growth factor [CTGF], and α-SMA) was performed, all primers are listed in Table S1, and data were normalized using β-actin expression (see supplemental Methods for details).
+ Open protocol
+ Expand
2

Culturing Endometrial Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
EC cell lines, including HEC-1-B, Ishikawa and RL95-2, and human endometrial stromal cells (hESC) were purchased from Procell (Wuhan, China) and cultured in 90% DMEM with 10% FBS, in a 37°C environment containing 5% CO2.
+ Open protocol
+ Expand
3

PTEN-proficient and PTEN-deficient EC cell lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
KLE (PTEN-proficient) and Ishikawa, RL-95-2, or AN3CA (PTEN-deficient) EC cell lines were purchased from Procell Life Science & Technology Co. Ltd (Wuhan, China). Clinicopathological features, molecular profiles, short tandem repeat information, and culture conditions of EC cell lines are tabulated in SI 2A. Details of the sgPTEN-pSpCas9(BB)-2A-Puro (PX459) V2.0 construct are summarized in SI 2B. hBAD or hBADS99A (Ser99 mutated to Ala99) construct with a flag-tag is described in SI 2F. Based on the PARP-trapping capacities [42 (link)–45 (link)] (SI4A), three PARPis, Olaparib (specific to PARP1/2). Rucaparib (pan-PARP) or Talazoparib (specific to PARP1) were utilized. Olaparib (AZD2281), Rucaparib (AG-014699), and Talazoparib (BMN 673) were purchased from SelleckChem (Houston, TX, USA). All experiments were performed in 2% FBS with the respective medium.
+ Open protocol
+ Expand
4

Lidocaine Induces Autophagy in Endometrial Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human endometrial stromal cells (THESCs) and the human endometrial cancer cell line RL95-2 were provided by the Procell Life Science & Technology Co., Ltd. Cells were cultured in DMEM (Gibco; Thermo Fisher Scientific, Inc.) containing 10% FBS (Gibco; Thermo Fisher Scientific, Inc.) and 1% penicillin-streptomycin at 37°C in a humidified incubator with 5% CO2. Subsequently, lidocaine (Beijing Solarbio Science & Technology Co., Ltd.) at different doss (5, 10 and 15 mM) was used to treat RL95-2 cells for 24, 48 and 72 h at 37°C. To further explore the underlying mechanism of lidocaine, 1 mM 3-methyladenine (3-MA) (Beijing Solarbio Science & Technology Co., Ltd.), an autophagy inhibitor, was used to treat RL95-2 cells for 3 min at room temperature after lidocaine pre-treatment.
+ Open protocol
+ Expand
5

Culture of Human Endometrial Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human endometrial cancer cell lines Ishikawa (cat. no. iCell-h113), RL95-2 (cat. no. iCell-h182), HEC-1-B (cat. no. iCell-h084), AN3CA (cat. no. icell-h018), and HEC-1-A (cat. no. iCell-h083) were purchased from iCell Bioscience, Inc. Ishikawa, AN3CA, and HEC-1-B cells were grown in MEM medium (Beijing Solarbio Science & Technology Co., Ltd.). HEC-1-A cells were cultured in McCoy's 5A medium (Procell Life Science & Technology Co., Ltd.). RL95-2 cells were cultured in DMEM/F12 medium (Procell Life Science & Technology Co., Ltd.). All the culture media were supplemented with 10% FBS (Sangon Biotech Co., Ltd.) and cells were cultured in a CO2 incubator at 37°C.
+ Open protocol
+ Expand
6

Culturing Endometrial Cancer and Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human endometrial cancer cell lines (Ishikawa, HEC-1A, RL95-2, HEC-1B and AN3CA) and human mononuclear cells (THP-1) were purchased from Procell Life Science & Technology Co., Ltd. All cells were cultured in Dulbecco's modified Eagle's medium (Gibco; Thermo Fisher Scientific, Inc.) containing 10% fetal bovine serum (FBS; Gibco; Thermo Fisher Scientific, Inc.), 100 µg/ml penicillin and 100 µg/ml streptomycin (HyClone; Cytiva) and cultured at 37˚C in 5% CO2.
+ Open protocol
+ Expand
7

Culturing Human Endometrial Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The two human endometrial cancer cell lines RL95-2 and AN3CA and the reagents associated with cell culture were obtained from Procell (Wuhan, China). RL95-2 cells were cultured in DMEM/F12 medium and AN3CA cells were cultured in MEM-modified medium. All cells were supplemented with 10% fetal bovine serum, 100 U/mL penicillin, and 100 µg/mL streptomycin. In addition, the culture medium for RL95-2 cells was supplemented with 5 µg/mL insulin. The cells were incubated at 37 °C in 95% humidified air and 5% CO2.
+ Open protocol
+ Expand
8

Endometrial Cancer Cell Lines Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
This study used six human endometrial cancer cell lines, Ishikawa (type I), Hec-1B (type II), AN3CA (type I), KLE (type II) and RL952 (type I) which were purchased from Procell Life Science & Technology Co., Ltd., and Hec-108 (type I) was obtained from Shanghai Huiying biological technology Co., Ltd. Ishikawa and Hec-108 were cultured in DMEM (SH30243.01, Hyclone), while others were maintained in DMEM/F12 (SH30023.01, Hyclone). Both were supplemented with 10% FBS (FB15015, Clark) and 1% penicillin/streptomycin (100 U/mL). Cell cultures were incubated at 37 °C in a humidified incubator under 5% CO2.
Olaparib (HY-10162) and ATM inhibitor, KU55933 (HY-12016), were purchased from MedChemExpress, dissolved in 50 mM stocks in DMSO and stored at −20 °C. The antibodies used in this study, including ATM (92356), Phospho-ATM (5883), PARP (9532), Caspase-3 (9662), cleaved Caspase-3 (9664), b-actin (3700) and horseradish peroxidase (HRP)-linked anti-mouse (7076)/rabbit (7074) IgG, were all purchased from Cell Signaling Technology.
+ Open protocol
+ Expand
9

Culturing Human Endometrial Epithelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human endometrial epithelial cells (hEECs, CP‐H058), human EC cell lines (Ishikawa (CL‐0283) and RL95‐2 (CL‐0197)), and the culture media were purchased from Procell in China. HEECs were incubated in hEEC complete culture medium (CM‐H058). Ishikawa cells were cultivated in Dulbecco's Modified Eagle Medium (DMEM, 30–2007) supplemented with 10% fetal bovine serum (FBS, 164210–500, Procell) and 1% penicillin–streptomycin solution (P/S, PB180120, Procell). RL95‐2 cells were cultured in DMEM/F12 medium (PM150312) blended with 5 μg/mL insulin (I9278, Sigma‐Aldrich), 10% FBS and 1% P/S. All cells were incubated at 37°C with 5% CO2.
+ Open protocol
+ Expand
10

Modulating E2F3 and DLEU1 in Endometrial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human EC cell lines (KLE, Ishikawa, RL95-2 and HEC-1A) were procured from Procell Life Science & Technology, Ltd (Wuhan, China). The human endometrial-stromal cell line (hESC) was procured from Otwo Biotech, Ltd (Shenzhen, China). The cells were grown in Roswell Park Memorial Institute (RPMI) 1640 medium containing 10% fetal bovine serum (FBS) at 37°C with 5% CO2. shRNA-negative control (sh-NC), shRNA-E2F3 (sh-E2F3) and shRNA-DLEU1-1/-2 (sh-DLEU1-1/-2) were procured from Sangon Biotech, Inc (Shanghai, China). Overexpression-DLEU1 (pcDNA-DLEU1), miR-381-3p mimics and their negative controls (pcDNA-NC, miR-NC) were all procured from Ribo Biotech, Ltd (Guangzhou, China). The cells were transfected with the aforementioned agents using a Lipofectamine RNAiMAX kit (Invitrogen, Carlsbad, CA, USA) for 48 h. At 48 h after transfection, the cells were harvested to perform the following experiments.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!